Chenyao Wu

ORCID: 0000-0002-5179-5064
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Nanoplatforms for cancer theranostics
  • Advanced Nanomaterials in Catalysis
  • MXene and MAX Phase Materials
  • Nanoparticle-Based Drug Delivery
  • Neuroscience and Neural Engineering
  • EEG and Brain-Computer Interfaces
  • 3D Printing in Biomedical Research
  • Hepatocellular Carcinoma Treatment and Prognosis
  • Advanced Photocatalysis Techniques
  • Advanced Memory and Neural Computing
  • Ovarian cancer diagnosis and treatment
  • Distributed and Parallel Computing Systems
  • Cancer Treatment and Pharmacology
  • Global Cancer Incidence and Screening
  • Cancer Research and Treatments
  • Photoacoustic and Ultrasonic Imaging
  • IoT and Edge/Fog Computing
  • Acute Ischemic Stroke Management
  • Immunotherapy and Immune Responses
  • Thermochemical Biomass Conversion Processes
  • Cervical Cancer and HPV Research
  • Electrospun Nanofibers in Biomedical Applications
  • Extracellular vesicles in disease
  • Cloud Computing and Resource Management
  • Advanced Neural Network Applications

Harbin Institute of Technology
2024

Sichuan University
2024

Shanghai University
2024

Center for Excellence in Brain Science and Intelligence Technology
2024

Institute of Automation
2020-2024

Chinese Academy of Sciences
2021-2024

University of Chinese Academy of Sciences
2020-2024

Kyoto University Institute for Chemical Research
2024

Kyoto University
2024

East China Normal University
2021-2023

Ferroptosis, an emerging type of cell death found in the past decades, features specifically lipid peroxidation during process commonly by iron accumulation. Unfortunately, however, direct delivery species may trigger undesired detrimental effects such as anaphylactic reactions normal tissues. Up to date, reports on cellular ferroptosis using nonferrous metal elements can be rarely found. In this work, we propose a ferroptosis-like strategy based hybrid CoMoO4-phosphomolybdic acid nanosheet...

10.1126/sciadv.abj8833 article EN cc-by-nc Science Advances 2021-09-22

One of the most sustainable and promising approaches for hydrogen peroxide (H2 O2 ) production in a low-cost environment-friendly way is photosynthesis, which, however, suffers from poor carrier utilization low H2 productivity. The addition proton donors such as isopropanol or ethanol can increase production, unfortunately, will inevitably elevate entire cost while wasting oxidizing power holes (h+ ). Herein, tetrahydroisoquinolines (THIQs) employed distinctive donor thermodynamically...

10.1002/adma.202210110 article EN Advanced Materials 2023-01-05

Abstract In this study, biocompatible Fe(III) species‐WS 2 ‐polyvinylpyrrolidone (Fe(III) @ WS ‐PVP) nanocapsules with enhanced biodegradability and doxorubicin (DOX) loading capacity are one‐pot synthesized. nanocapsule, there exists a redox reaction between species to form Fe 2+ WO 4 2− . The formed could be oxidized 3+ , which reacts ‐PVP again continuously produce Such repeated endogenous leads an biodegradation DOX release of ‐PVP. More strikingly, the generation further accelerated by...

10.1002/adfm.201901722 article EN Advanced Functional Materials 2019-05-01

As an emerging therapeutic gas, hydrogen (H2) is gifted with excellent biosafety, high tissue permeability, and radical-trapping capacity extensively considered as a highly promising antioxidant in clinics. However, facile effective strategy of H2 production for major inflammatory disease treatments still lacking. In this study, by wet-chemical exfoliation synthesis, hydrogen-terminated silicon nanosheet (H-silicene) has been synthesized, which can favorably react environmental water to...

10.1021/jacs.2c04412 article EN Journal of the American Chemical Society 2022-07-13

Iodine, as a typical haloid element in group VIIA, has been extensively applied antiseptics clinically, thanks to its effective and wide-spectrum antimicrobial activity against bacteria, fungi, viruses. Nevertheless, current iodic sterilizing agents are still limited topical applications such instrument sterilization treatments of skin or mucous membrane infection due unsatisfactory stability biocompatibility. Here, we propose an emerging two-dimensional iodine nanomaterial (noted iodinene)...

10.1021/jacs.3c02669 article EN Journal of the American Chemical Society 2023-06-07

10.1016/j.colsurfa.2019.124004 article EN Colloids and Surfaces A Physicochemical and Engineering Aspects 2019-09-21

Reactive oxygen species (ROS) play a crucial role in orchestrating myriad of physiological processes within living systems. With the advent materdicine, an array nanomaterials has been intricately engineered to influence redox equilibrium biological milieus, thereby pioneering distinctive therapeutic paradigm predicated on ROS-centric biochemistry. Among these, two-dimensional carbides, nitrides, and carbonitrides, collectively known as MXenes, stand out due their multi-valent...

10.1002/cplu.202300777 article EN ChemPlusChem 2024-02-15

Abstract Acute kidney injury (AKI) is a sudden dysfunction caused by aberrant reactive oxygen species (ROS) metabolism that results in high clinical mortality. The rapid development of ROS scavengers provides new opportunities for AKI treatment. Herein, the use hydrogen‐terminated germanene (H‐germanene) nanosheets reported as an antioxidative defense nanoplatform against mice. simulation show 2D H‐germanene can effectively scavenge through free radical adsorption and subsequent redox...

10.1002/advs.202202933 article EN cc-by Advanced Science 2022-10-06

<i>Objective:</i> To analyze the efficacy of oral thalidomide in treatment advanced hepatocellular carcinoma (HCC). <i>Methods:</i> Sixty-eight patients with unresectable and nonembolizable HCC were consecutively enrolled a compassionate program thalidomide. Tumor response treatment-related toxicity prospectively followed. Thalidomide was given at starting dose 200 mg per day. The gradually escalated 100-mg steps up to 600 day if no limiting toxicities developed....

10.1159/000074477 article EN Oncology 2003-01-01

Since 2006, the human papillomavirus (HPV) vaccine has been recommended for females aged 9-26 years in United States. Aiming to evaluate early effect of HPV on cervical cancer, this study assessed incidence cancer by age and histology before after introduction vaccination.

10.3389/fpubh.2022.998174 article EN cc-by Frontiers in Public Health 2023-01-06
Coming Soon ...